9 results

• FDA Puts New Stomach Cancer Restrictions in Place for Keytruda, Opdivo

  June 10, 2025

  Irvin Jackson

  Federal regulators have sent letters to Merck and Bristol-Myers Squibb, announcing new restrictions on the use of Keytruda and Opdivo for the treatment of stomach cancer.

• FDA Advisors Vote for Restrictions on Opdivo, Keytruda, Similar Stomach Cancer Drugs

  September 30, 2024

  Irvin Jackson

  Independent scientific advisory board is calling for restrictions on stomach cancer drugs like Keytruda and Opdivo, saying they do little to extend the lives of certain cancer patients.

• FDA Advisors Set to Consider Stomach Cancer Restrictions for Yervoy, Opdivo, Keytruda

  August 23, 2024

  Irvin Jackson

  An FDA advisory committee has been asked to determine if there should be restrictions on the use of some popular cancer drugs, like Opdivo and Keytruda, for the treatment of stomach cancer, following years of concerns about the drugs' safety risks.

• FDA Approves Opdivo, Yervoy Drug Combo To Treat Mesothelioma

  October 5, 2020

  Irvin Jackson

  The FDA has approved the use of a drug combination of Opdivo and Yervoy as a first-line treatment for mesothelioma.

• Yervoy, Keytruda Linked To Muscoskeletal Immune-Related Adverse Event Problems: Study

  March 26, 2018

  Irvin Jackson

  The side effects of Yervoy, Keytruda and other similar cancer drugs may increase the risk of musculoskeletal problems, according to the findings of a new study.

• Opdivo/Yervoy Drug Combo Toxic For Most Cancer Patients: Study

  August 24, 2017

  Irvin Jackson

  A new study warns that combination cancer therapy involving Opdivo and Yervoy may often be too toxic for patients, resulting in hospitalizations and emergency room visits due to immune system adverse events.

• Opdivo, Yervoy Treatments May Slow Mesothelioma Progression: Study

  June 14, 2017

  Irvin Jackson

  The cancer drugs Opdivo and Yervoy may slow the progression of mesothelioma, according to the findings of a new study.

• Side Effects of Opdivo and Yervoy May Be Linked To Fatal Heart Risk: Study

  November 8, 2016

  Irvin Jackson

  Two Bristol-Myers Squibb cancer drugs, Opdivo and Yervoy, may be linked to fatal heart problems when used in combination, according to the findings of a new study.

• Cancer Drugs Yervoy and Opdivo May Increase Risk of Arthritis: Study

  July 5, 2016

  Irvin Jackson

  The cancer drugs Yervoy and Opdivo could increase the risk of arthritis, according to the findings of a new case study.